Cardinal Health (CAH) shares rose approximately 17.46% over the past 30 days, significantly outperforming broader market benchmarks. The stock reached new 52-week highs near $240 amid strong momentum and favorable analyst sentiment.

COR stock declined approximately -18% over the past 30 days, driven primarily by a post-earnings selloff after missing revenue expectations in fiscal Q2 2026. Over the past quarter, the stock is down around -28%, reflecting broader sector pressures and decelerating growth amid biosimilar conversions and slower GLP-1 demand.

McKesson reported Q4 fiscal 2026 adjusted EPS of $11.69, beating consensus estimates of $11.56 by 1.1%. Quarterly revenue reached $96.3 billion, up 6% year-over-year but below expectations of about $101 billion.

Cencora (COR) shares plunged 18.20% in early trading on May 6, 2026, following the release of fiscal Q2 2026 earnings before the market open. The company reported adjusted EPS of $4.75, slightly beating consensus estimates of $4.74-$4.80, but revenue of $78.4 billion missed expectations of around $81 billion.

Analysts expect Q4 fiscal 2026 EPS of approximately $11.56–$11.57, a 14% year-over-year increase. Consensus revenue estimate stands at $101.4 billion, reflecting 12% growth from last year.

MCK stock declined -8% over the past 30 days amid analyst price target adjustments and concerns over GLP-1 drug pricing pressures, despite solid fundamentals. Over the past quarter, the stock rose +3%, supported by strong Q3 fiscal 2026 earnings that beat estimates and raised full-year guidance.

The medical companies segment has experienced a notable increase in performance, recording a weekly gain of +3.53%. This sector encompasses companies involved in the production and supply of pharmaceuticals and essential medical products, catering to a broad spectrum of healthcare needs. Their product offerings include surgical apparel, gloves, hospital furniture, fluid management solutions, and specialized equipment for cosmetic and surgical procedures.

Discover the pulse of the Medical Distributors sector with a healthy 5.61% monthly rise, led by $CAH, $MCK, $HSIC, $OMI, and $PDCO. Unravel the dynamics behind this sector's growth and what it spells for future market trends.

The pets industry, encompassing various businesses related to the healthcare and daily needs of our furry friends, has recently been a hot topic among investors.

"Explore the latest surge in Medical Distributors! 🚀 Dive deep into market movements, volume buzz, and insightful ticker analysis for informed trading decisions. 📊🔍"

The Medical Distributors industry has been making headlines recently with a significant increase in its performance, demonstrating a notable +6.34% growth over the past week. This sector plays a crucial role in the healthcare ecosystem, providing services such as pharmaceutical product distribution, medical device distribution, and biopharmaceutical product distribution. Some well-known players in this industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc., and Patterson Companies, Inc.

Cosmos Health Inc. announced that it has revised a non-binding letter of intent to buy telemedicine business ZipDoctor Inc. The healthcare company said it renegotiated the price "to achieve much improved payment terms." The updated letter will remain effective until February 15, 2023. ZipDoctor is a wholly owned subsidiary of American International Holdings Corp., and is a direct-to-consumer...

Medical equipment and pharmaceutical supplier McKesson (NYSE: MCK) is set to report earnings on January 31.McKesson hasn’t been under $100 since early 2013, but the trend has been to the downside since the stock hit an all-time high of $236.52 back in May 2015. The company’s fundamentals are mixed with a decent return on equity, but slow earnings growth, sales growth, and a low profit margin.

The company, which distributes pharmaceutical products and provides healthcare technology, said that it will move 500 employees from San Francisco to elsewhere around the country and would retain 1,400 jobs in California. “We are excited to strengthen our presence in Texas and make Las Colinas our official global headquarters,” said John Hammergren, CEO of McKesson, in a statement.“Making this move will improve efficiency, collaboration and cost-competitiveness, while providing an exceptional work environment for our employees.” (as reported by San Francisco Chronicle). McKesson generated revenue of $198 billion last year, the sixth highest among U.S. public companies.